CIM
EXEL icon

CIM Investment Management’s Exelixis EXEL Stock Holding History

CIM Investment Management’s Portfolio EXEL Stock Details EXEL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-10,228
Closed -$187K – 270
2021
Q4 		$187K Buy
+10,228
New +$196K 0.06% 290

Other funds holding EXEL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
MG
Meditor Group Hamilton, Bermuda $48.1M AUM 38.67% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

CIM Investment Management's EXEL Position: Q1 2022 in Review

CIM Investment Management sold out of Exelixis (EXEL) in Q1 2022, closing a stake of 10,228 shares — an estimated $187K sold.

CIM Investment Management first reported a position in EXEL in Q4 2021 and held it in 1 quarter. The position peaked at $187K in Q4 2021. 363 funds tracked by Wall St. Rank hold EXEL as of Q1 2022.

  • CIM Investment Management reported no remaining Exelixis position as of Q1 2022 after selling out during the quarter.
  • CIM Investment Management sold 10,228 Exelixis shares in Q1 2022, an estimated $187K.
  • CIM Investment Management first reported a position in Exelixis in Q4 2021 and held it in 1 quarter.
  • CIM Investment Management's Exelixis position peaked at $187K in Q4 2021.
  • 363 funds tracked by Wall St. Rank held Exelixis as of Q1 2022.

Based on CIM Investment Management's 13F filing for Q1 2022, filed 17 May 2022.